Immune checkpoint inhibitor and MR-guided radiation “booster shot” in situ tumor vaccination in patients with limited metastatic carcinoma: interim analysis of a single-arm phase 2 trial

Michael Chuong; Noah Kalman; Federico Albrecht; Paul Kaywin; Guilherme Rabinowits; Carolina Rojas; Minesh Mehta; Rupesh Kotecha

Immune checkpoint inhibitor and MR-guided radiation “booster shot” in situ tumor vaccination in patients with limited metastatic carcinoma: interim analysis of a single-arm phase 2 trial

Michael Chuong
, Noah Kalman
, Federico Albrecht
, Paul Kaywin
, Guilherme Rabinowits
, Carolina Rojas
, Minesh Mehta
, Rupesh Kotecha

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Jun 19 2022

Cite this

@conference{734438f8c4ad43388b24bf0e7355d7fa,

title = "Immune checkpoint inhibitor and MR-guided radiation “booster shot” in situ tumor vaccination in patients with limited metastatic carcinoma: interim analysis of a single-arm phase 2 trial",

author = "Michael Chuong and Noah Kalman and Federico Albrecht and Paul Kaywin and Guilherme Rabinowits and Carolina Rojas and Minesh Mehta and Rupesh Kotecha",

year = "2022",

month = jun,

day = "19",

language = "American English",

}

TY - CONF

T1 - Immune checkpoint inhibitor and MR-guided radiation “booster shot” in situ tumor vaccination in patients with limited metastatic carcinoma: interim analysis of a single-arm phase 2 trial

AU - Chuong, Michael

AU - Kalman, Noah

AU - Albrecht, Federico

AU - Kaywin, Paul

AU - Rabinowits, Guilherme

AU - Rojas, Carolina

AU - Mehta, Minesh

AU - Kotecha, Rupesh

PY - 2022/6/19

Y1 - 2022/6/19

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/4667

M3 - Presentation

ER -

Immune checkpoint inhibitor and MR-guided radiation “booster shot” in situ tumor vaccination in patients with limited metastatic carcinoma: interim analysis of a single-arm phase 2 trial

Other files and links

Cite this